Eucerin AtoControl Acute Care Cream
€15.40
Product details:
Intensive care cream for flare-ups of Atopic Dermatitis
Atopic skin is dry irritable and itchy. This itchiness induces scratching which triggers the itch-scratch cycle. Symptoms worsen and can get in the way of a good night?s sleep and have a negative impact on quality of life.
Eucerin AtopiControl Acute Care Cream has been specially formulated to offer relief and intensive care for skin undergoing a flare-up of Atopic Dermatitis. The formula has a unique active ingredient complex of soothing Licochalcone A anti-bacterial Decanediol and anti-itching and cooling Methoxypropandiol (MPD). This complex combined with a high concentration of Ceramides strengthens skin?s barrier alleviates dryness and relieves itchiness at a sensory level thereby reducing the need to scratch.
Fragrance-free the cream for Atopic Dermatitis flare-ups can be applied as often as needed on affected areas and has been shown to support sleep and improve quality of life for those with Atopic Dermatitis. Suitable for adults children and babies over three months.
Clinical and dermatological studies
Very good care efficacy and skin tolerability proven on atopic skin
Main findings
In a Product in Use (PiU) test Eucerin AtopiControl Acute Care Cream was used alongside Eucerin AtopiControl Lotion by a sample of 144 men and women all aged 30+ with mild and moderate Atopic Dermatitis. After four weeks of daily use they reported the following results:
Improves skin condition
97% agreed with the statement that the products ?Improve skin condition?
Supports better sleep
96% agreed that with the products ?I don?t need to scratch a lot during the night?
94% agreed that with the products they weren?t ?waking up early due to skin problems?
93% agreed that during the trial period they woke up ?less often during the night?
89% agreed that the products help them to ?wake up well-rested?
88% agreed that the products helped them to have a ?good energy level during the day?
Improves quality of life
Before the trial 92% of the sample agreed that Atopic Dermatitis affected their quality of life. After four weeks of using the AtopiControl products only 38% of the sample agreed that the disease affected their quality of life. From this we can infer that as a result of using the products 54% of the sample felt there was an improvement in their quality of life
